RU2018121107A - Набор реагентов для выявления маркера эпителиальных карцином - Google Patents

Набор реагентов для выявления маркера эпителиальных карцином Download PDF

Info

Publication number
RU2018121107A
RU2018121107A RU2018121107A RU2018121107A RU2018121107A RU 2018121107 A RU2018121107 A RU 2018121107A RU 2018121107 A RU2018121107 A RU 2018121107A RU 2018121107 A RU2018121107 A RU 2018121107A RU 2018121107 A RU2018121107 A RU 2018121107A
Authority
RU
Russia
Prior art keywords
epitelial
identification
reagent kit
detection
carcinoma marker
Prior art date
Application number
RU2018121107A
Other languages
English (en)
Other versions
RU2018121107A3 (ru
RU2735918C2 (ru
Inventor
Жаннета Рашидовна Черкасова
Сергей Александрович Цуркан
Вячеслав Борисович Кондратьев
Original Assignee
Общество с ограниченной ответственностью "ДЖЕЙВИС ДИАГНОСТИКС"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ДЖЕЙВИС ДИАГНОСТИКС" filed Critical Общество с ограниченной ответственностью "ДЖЕЙВИС ДИАГНОСТИКС"
Priority to RU2018121107A priority Critical patent/RU2735918C2/ru
Publication of RU2018121107A publication Critical patent/RU2018121107A/ru
Publication of RU2018121107A3 publication Critical patent/RU2018121107A3/ru
Priority to PCT/RU2019/050069 priority patent/WO2019235973A1/ru
Priority to US16/972,895 priority patent/US20220057401A1/en
Priority to EA202090834A priority patent/EA039873B1/ru
Application granted granted Critical
Publication of RU2735918C2 publication Critical patent/RU2735918C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Claims (1)

  1. Набор реагентов для выявления маркера эпителиальных карцином СА-62 в сыворотке крови пациентов при ранней диагностике рака, выявлении рецидивов и мониторинге лечения эпителиальных опухолей человека методом иммунохимического анализа, обладающего высокой чувствительностью и специфичностью, отличной от всех имеющихся в настоящее время сывороточных маркеров, и включающий в себя планшет с иммобилизованными антителами к раковому антигену СА-62, конъюгат «СА-62-Акридин», стандартные калибраторы СА-62 в диапазоне измерений от 10 до 30000 Ед/мл, включающий или не включающий положительный контроль СА-62, рабочий буферный раствор, рН от 2,0 до 8,0, содержащий Твин-80.
RU2018121107A 2018-06-07 2018-06-07 Набор реагентов для выявления маркера эпителиальных карцином RU2735918C2 (ru)

Priority Applications (4)

Application Number Priority Date Filing Date Title
RU2018121107A RU2735918C2 (ru) 2018-06-07 2018-06-07 Набор реагентов для выявления маркера эпителиальных карцином
PCT/RU2019/050069 WO2019235973A1 (ru) 2018-06-07 2019-05-28 Набор реагентов для выявления маркера эпителиальных карцином
US16/972,895 US20220057401A1 (en) 2018-06-07 2019-05-28 Set of reagents for detecting a marker of epithelial carcinomas
EA202090834A EA039873B1 (ru) 2018-06-07 2019-05-28 Набор реагентов для выявления маркера эпителиальных карцином

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018121107A RU2735918C2 (ru) 2018-06-07 2018-06-07 Набор реагентов для выявления маркера эпителиальных карцином

Publications (3)

Publication Number Publication Date
RU2018121107A true RU2018121107A (ru) 2018-07-25
RU2018121107A3 RU2018121107A3 (ru) 2019-03-28
RU2735918C2 RU2735918C2 (ru) 2020-11-10

Family

ID=62981387

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018121107A RU2735918C2 (ru) 2018-06-07 2018-06-07 Набор реагентов для выявления маркера эпителиальных карцином

Country Status (4)

Country Link
US (1) US20220057401A1 (ru)
EA (1) EA039873B1 (ru)
RU (1) RU2735918C2 (ru)
WO (1) WO2019235973A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113311056B (zh) * 2021-05-10 2022-06-21 中国医学科学院北京协和医院 用于遗传性血管水肿的标志物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1915626B1 (en) * 2005-08-16 2011-11-09 Genentech, Inc. Apoptosis sensitivity to apo2l/trail by testing for galnac-t14 expression in cells/tissues
EP2287197A1 (en) * 2009-08-21 2011-02-23 Pierre Fabre Medicament Anti-cMET antibody and its use for the detection and the diagnosis of cancer
JP6192123B2 (ja) * 2012-01-09 2017-09-06 スージョウ マイクロダイアグ バイオメディスン カンパニー リミテッド 乳癌の予測および診断のためのバイオマーカー
RU2599890C2 (ru) * 2014-04-17 2016-10-20 Федеральное государственное бюджетное учреждение науки Российской академии наук Институт молекулярной биологии им. В.А. Энгельгардта Российской академии наук (ИМБ РАН) Многопараметрическая диагностическая тест-система, предназначенная для обнаружения и мониторинга терапии рака молочной железы и рака яичников, и способ проведения анализа с ее использованием

Also Published As

Publication number Publication date
WO2019235973A1 (ru) 2019-12-12
RU2018121107A3 (ru) 2019-03-28
RU2735918C2 (ru) 2020-11-10
EA039873B1 (ru) 2022-03-22
EA202090834A1 (ru) 2020-07-06
US20220057401A1 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
RU2008103608A (ru) Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела
ATE490465T1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
Bagherbaigi et al. Cotton fabric as an immobilization matrix for low-cost and quick colorimetric enzyme-linked immunosorbent assay (ELISA)
RU2014111182A (ru) Способ обнаружения злокачественных опухолей
JP2009540281A5 (ru)
CN103792364A (zh) 用于检测外周血中循环肿瘤细胞ror1蛋白的试剂及其应用
CN102043058A (zh) 用于预测肿瘤的乙酰金刚烷胺的检测试剂盒
CN101424661B (zh) 一种活动性肺结核病的血清诊断模型的建立方法
CN105548547A (zh) 基于流式细胞仪的检测肺癌标志物的流式阵列免疫分析试剂盒
US20160245804A1 (en) Methods, Systems and Kits of Fecal NGal Rapid Immunochromatographic Test
RU2018121107A (ru) Набор реагентов для выявления маркера эпителиальных карцином
WO2013104103A1 (zh) 诊断和预示肠癌的标志物
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
US11242408B2 (en) Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
BRPI1004526A2 (pt) dispositivo semi-quantitativo de immunochromatographico e método para a determinação de hiv/aids via medida de solúvel cd40 ligand/cd154, um cd4+ equivalente de célula de t e a detecção simultánea de infecção de hiv via detecção de anticorpo de hiv
RU2014115399A (ru) Многопараметрическая диагностическая тест-система, предназначенная для обнаружения и мониторинга терапии рака молочной железы и рака яичников, и способ проведения анализа с ее использованием
CN105158474A (zh) 一种用于检测血清her2的试剂盒及用途
CN109085355A (zh) 血清蛋白标志物组合在肺癌筛查和诊治中的应用
CN108761082A (zh) 一种定量检测血清lrpprc的抗体组合及试剂盒
US20140273016A1 (en) Device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers
CN103562722A (zh) 一种区分甲状腺癌变的方法、实施该方法的试剂盒以及金属硫蛋白在区分甲状腺癌变中的用途
CN115112889A (zh) 抗原组合在制备肺癌的检测试剂或试剂盒中的用途
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
Tang et al. Significance of incorporation of DNMT1 and HLA-DRα with TNM staging in patients with hepatocellular carcinoma after curative resection
US20130084587A1 (en) Levels of cytokeratins in blood and body fluids as biomarkers for cancer screening, diagnosis and treatment monitoring

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20211202

Effective date: 20211202